Friday, July 31, 2026

Hyundai and Kia Hit 30K EV Sales in U.S.—IONIQ 5 Leads the Charge

Hyundai Motor Group sold over 30,000 electric vehicles in the U.S. in Q1 2025, ranking third in the market with the IONIQ 5 leading sales.

Everything You Need to Know About Jennie’s Upcoming Single “Less than a Lover” – Release Date and Teaser Insights

BLACKPINK's Jennie will release her solo single "Less than a Lover" on July 24, showcasing her creative involvement and mature sound.

Smallest Long-Period Super-Earth Discovered 14,000 Light-Years Away

A new Super-Earth exoplanet, 1.3 times Earth's mass, was discovered 14,000 light-years away, revealing insights into planetary formation.

Tag: biopharmaceuticals

North KoreaKoreaKimMilitaryAISouth KoreamarketrelationsInternational

Unlocking Opportunities: 2025 Bio GMP Training Program Launches at Daejeon University

Daejeon University launched the 2025 Winter BioRG Training Program for biopharmaceuticals, featuring industry experts and hands-on sessions.

Samsung Biologics Unveils Three-Pillar Growth Strategy: How Capacity, Portfolio, and Global Expansion Shape 2026

Samsung Biologics outlines a growth strategy focused on production, portfolio, and global expansion to enhance its CDMO position.

2026: South Korea’s Advanced Regenerative Medicine R&D Investment Expands – What You Need to Know!

The Ministry of Health and Welfare aims to boost investments in advanced regenerative medicine R&D and improve research infrastructure in South Korea.

GAME OVER: Samsung Biologics Declares War With ‘ExellenS’—A Standard That Kills All Biotech Competition

Samsung Biologics launches ExellenS in Europe, enhancing biopharmaceutical production with standardized quality and efficiency.

Samsung Bioepis Taps Harrow to Take Over U.S. Ophthalmic Drug Rights from Biogen

Samsung Bioepis partners with Harrow to sell ophthalmic treatments in the U.S., transferring rights from Biogen by 2025.

Top News

- Our Sponsors Ad -

Follow us

Cars

Tech

future

health

© Copyright by News1. All Rights Reserved.